Dr. Christopher
Bredeson received a medical degree (cum laude) from the University of Ottawa. His post-doctorate training included an internship and
residency in internal medicine at The Ottawa Hospital, as well as a residency
in clinical hematology and a fellowship in the Leukemia/Bone Marrow Transplant
Program at the University of British Columbia in Vancouver. He holds a Masters
degree in Clinical Epidemiology also from the University of Ottawa.
Dr. Bredeson
returned to Ottawa in 2011 after a decade at the Medical College of Wisconsin
where he was a Scientific Director at the Center for International Blood and
Marrow Transplant Research. While there he participated in the establishment of
the NIH funded Blood and Marrow Transplant Clinical Trials Network and designed
and ran several of their early trials.
Dr. Bredeson returned to Ottawa to run the Malignant Hematology and Stem Cell Transplantation Programme
at The Ottawa Hospital.
Dr Bredeson is a
Professor in the Faculty of Medicine and Senior Scientist at the Ottawa Hospital
Research Institute.
1. Sanders S, Bredeson C, Pringle CE, Martin L, Allan D,
Bence-Bruckler I,Hamelin L, Hopkins HS, Sabloff M, Sheppard D, Tay J, Huebsch
L, Atkins HL. Autologous Stem Cell Transplantation for Stiff Person Syndrome:
Two Cases From the Ottawa Blood and Marrow Transplant Program. JAMA Neurol.
2014 Aug 25.
2. Bredeson C,
LeRademacher J, Kato K, Dipersio JF, Agura E, Devine SM, Appelbaum FR, Tomblyn
MR, Laport GG, Zhu X, McCarthy PL, Ho VT, Cooke KR, Armstrong E, Smith A, Rizzo
JD, Burkart JM, Pasquini MC. Prospective cohort study comparing
intravenous
busulfan to total body irradiation in hematopoietic cell transplantation.
Blood. 2013 Dec 5;122(24):3871-8.
3. Anasetti C, Logan BR, Lee SJ, Waller
EK, Weisdorf DJ, Wingard JR, Cutler CS,
Westervelt P, Woolfrey A, Couban S,
Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S,
McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson
C, Carter SL, Horowitz MM, Confer DL; Blood and Marrow Transplant Clinical
Trials Network. Peripheral-blood stem cells versus bone marrow from unrelated
donors. N Engl J Med. 2012 Oct 18;367(16):1487-96.
4. Sheppard D,
Bredeson C, Allan D, Tay J. Systematic review of randomized
controlled
trials of hematopoietic stem cell mobilization strategies for
autologous
transplantation for hematologic malignancies. Biol Blood Marrow
Transplant.
2012 Aug;18(8):1191-203.
5. Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo
A, Bahlis NJ, Ballen K, Brown C,
Chaudhry MA, Horowitz MM, Kurian S,
Quinlan D, Muehlenbien CE, Russell JA, Savoie L, Rizzo JD, Stewart DA. Outcomes
following HSCT using fludarabine, busulfan, and thymoglobulin: a matched
comparison to allogeneic transplants conditioned with busulfan and
cyclophosphamide. Biol Blood Marrow Transplant. 2008 Sep;14(9):993-1003.
